Previous studies have revealed that accumulated BIRC3 contributes to tumor progression in several malignancies (46, 47), and the expression levels of BIRC3 have been shown to be correlated with prognosis of patients with different cancers (48, 49). Here, BIRC3 is linked to neoplasm.